Bumetanide
| Clinical data | |
|---|---|
| Trade names | Bumex, Burinex, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a684051 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | By mouth, intravenous, intramuscular |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | Almost complete (~80%) |
| Protein binding | 97% |
| Metabolism | Liver |
| Elimination half-life | ~0.8 hours |
| Excretion | Kidney |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.044.534 |
| Chemical and physical data | |
| Formula | C17H20N2O5S |
| Molar mass | 364.42 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Bumetanide, sold under the brand name Bumex among others, is a medication used to treat swelling and high blood pressure.[1] This includes swelling as a result of heart failure, liver failure, or kidney problems.[1] It may work for swelling when other medications have not.[1] For high blood pressure it is not a preferred treatment.[1] It is taken by mouth, or by injection into a vein or muscle.[1] Effects generally begin within an hour and last for about six hours.[1]
Common side effects include dizziness, low blood pressure, low blood potassium, muscle cramps, and kidney problems.[1] Other serious side effects may include hearing loss and low blood platelets.[1] Blood tests are recommended regularly for those on treatment.[1] Safety during pregnancy and breastfeeding is unclear.[2] Bumetanide is a loop diuretic and works by decreasing the reabsorption of sodium by the kidneys.[3][1]
Bumetanide was patented in 1968 and came into medical use in 1972.[4] It is on the World Health Organization's List of Essential Medicines.[5] It is available as a generic medication.[3] In 2020, it was the 270th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[6][7]
- ^ a b c d e f g h i j "Bumetanide Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 8 April 2019.
- ^ "Bumetanide (Bumex) Use During Pregnancy". Drugs.com. Retrieved 8 April 2019.
- ^ a b British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. pp. 225–226. ISBN 978-0-85711-338-2.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 458. ISBN 978-3-527-60749-5.
- ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
- ^ "The Top 300 of 2020". ClinCalc. Retrieved 7 October 2022.
- ^ "Bumetanide - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022.